TransCode Therapeutics, Tonix Pharmaceuticals, GeoVax Labs, BioCorRx Inc., Lifespring Chiropractic, Silicon Valley Hair Institute, Collaborative Bridges, and Ourian Plastic Surgery announce significant updates in the biotech, healthcare, and wellness sectors.

HeartBeam to discuss software clearance at JP Morgan Conference; Telomir Pharmaceuticals reports positive results for Telomir-1 in breast cancer study.

Kemal Erkan reaches 200k YouTube subscribers, Ethema Health terminates partnership, Nutriband Inc. CEO shares achievements and outlook, Profound Medical Corp. closes $36M offering.

Kemal Erkan celebrates YouTube milestone, Ethema Health ends partnership, Nutriband and Profound Medical share company updates.

Lionheart Health, Inc. has developed a bioelectric stimulation platform to improve peptide uptake and effectiveness in various delivery methods. This innovation targets healthspan pathways, enhancing absorption and signaling efficiency for peptides like klotho and sirtuins. Early data suggests a significant increase in efficacy, potentially allowing for lower doses with the same impact, positioning Lionheart Health as a leader in optimizing peptide and protein activity.

Lexaria Bioscience Corp. showcases the potential benefits of its DehydraTECH platform technology in a Phase 1b study, while Wellness Eternal highlights the top verified wellness and longevity companies. Additionally, Freedom at The Mat introduces an AI-generated brand anthem for relaxation, and Med Clinic Authority offers a scalable platform for launching modern telehealth clinics.

Tonix Pharmaceuticals Holding Corp. provided updates on TNX-4800, a long-acting antibody for Lyme disease prophylaxis, while also announcing a $20 million offering for product development. Nutriband Inc. sold a majority stake in Pocono Pharmaceutical to fund the development of an abuse-deterrent fentanyl patch. Additionally, experts are exploring the impact of screen time and lifestyle on pediatric brain tumors, with companies like CNS Pharmaceuticals Inc. working on new therapeutics.

Branded Legacy, Inc. (OTC: BLEG) eliminates $1 million in legacy debt to improve financial flexibility under new leadership, while NavioMD launches a telehealth platform emphasizing clinician-guided care and responsible telehealth practices, aiming to meet the increasing demand for accessible healthcare solutions.

The Personalised Pain Reset Planner by Analgesia is a new digital tool in the UK designed to help individuals with chronic back and nerve pain manage their symptoms by tracking, understanding, and managing pain patterns. By combining structured pain tracking with an Anti-Inflammatory Lifestyle Blueprint, users gain clarity and insight into how movement, sleep, stress, and daily habits interact with their pain. This planner, available online from December 29, 2025, provides a self-management approach for personalized and sustainable solutions for chronic pain.

The progress in Radionuclide Drug Conjugates (RDCs) research for cancer management is highlighted, showcasing precision tumor targeting and personalized therapy. Prof. Hongyun Wang emphasizes RDCs' potential for accurate diagnoses and effective treatment. Meanwhile, Avantor, Inc. appoints Gladys Wang as Vice President for Bioprocessing Commercial in Asia, Middle East, and Africa, aiming to drive business expansion and enhance customer success in the region.